Greater Glasgow and Clyde Medicines
Key to symbols The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP The medicine should only be used and prescribed by a specialist Indicates the preferred choice within a class or group of medicines
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
10.2. Drugs used in neuromuscular disorders

10.2.3. Other neuromuscular drugs

Total Formulary
Specialist Only
MEXILETINE (Namuscla) (167mg capsules)

Restrictions:

Restricted to specialist use for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic disorders.

Prescribing Notes:

For other indications please see section 2.3.2

BNF Link

Specialist Only
RISDIPLAM (Evrysdi)

Restrictions:

Restricted to specialist use only in the treatment of 5q spinal muscular atrophy (SMA) in patients 2 months of age and older, with a clinical diagnosis of SMA type 1, type 2 or type 3 or with one to four SMN2 [survival of motor neuron 2] copies.

Prescribing Notes:

Available via the Ultra Orphan Pathway with reassessment by SMC following 3 years of data collection. Appropriate paperwork needs completing before prescribing to ensure registration on the national risk sharing scheme.

BNF Link

Specialist Only
VAMOROLONE (AGAMREE)

Restrictions:

Restricted to specialist use for treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and older.

BNF Link